Zdrowie i gospodarka · 16/10/2017

FDA Classifies Nucleic Acid-Based Device for Microbial Pathogen Detection

The FDA is classifying a nucleic acid-based device for detecting microbial pathogens directly from whole blood specimens into Class II, requiring special controls, to ensure safety and effectiveness. This move aims to reduce regulatory burdens and enhance patients' access to innovative devices.